Es gab 50 kürzliche Insider-Transaktionen für Vigil Neuroscience, Inc. (VIGL), darunter 37 Käufe und 11 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $9.35M und die gesamten Insider-Verkäufe auf $11.29M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Thistle Mary, Blanchard Cheryl R, Booth Bruce. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — VIGL
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-05-22 |
Thistle Mary |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2025-05-22 |
Blanchard Cheryl R |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2025-05-22 |
Booth Bruce |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2025-05-22 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2025-05-22 |
Vitorovic Stefan |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2025-05-22 |
Koenig Gerhard |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2025-05-22 |
Budd Haeberlein Samantha L. |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
17,000 |
| 2025-03-03 |
Magovcevic-liebisch Ivana |
President and CEO |
RSU-Zuteilung |
485,000 |
$2.19 |
$1.06M |
485,000 |
| 2025-03-03 |
Booth Bruce |
Director |
RSU-Zuteilung |
48,393 |
$2.19 |
$105.98K |
48,393 |
| 2025-03-03 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
33,875 |
$2.19 |
$74.19K |
33,875 |
| 2025-03-03 |
Ziolkowski Jennifer Lynn |
Chief Financial Officer |
RSU-Zuteilung |
156,000 |
$2.19 |
$341.64K |
156,000 |
| 2025-03-03 |
Kaufmann Petra |
Chief Medical Officer |
RSU-Zuteilung |
144,000 |
$2.19 |
$315.36K |
144,000 |
| 2025-03-03 |
Gray David L. F. |
Chief Science Officer |
RSU-Zuteilung |
125,000 |
$2.19 |
$273.75K |
125,000 |
| 2024-12-19 |
Magovcevic-liebisch Ivana |
President and CEO |
Informierter Kauf |
5,000 |
$1.68 |
$8.4K |
222,687 |
| 2024-12-19 |
Budd Haeberlein Samantha L. |
Director |
Informierter Kauf |
12,000 |
$1.71 |
$20.52K |
12,000 |
| 2024-12-18 |
Magovcevic-liebisch Ivana |
President and CEO |
Informierter Kauf |
5,000 |
$1.67 |
$8.35K |
217,687 |
| 2024-12-05 |
Magovcevic-liebisch Ivana |
President and CEO |
Informierter Kauf |
5,000 |
$2.34 |
$11.7K |
212,687 |
| 2024-06-05 |
Thistle Mary |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-06-05 |
Blanchard Cheryl R |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-06-05 |
Booth Bruce |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-06-05 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-06-05 |
Vitorovic Stefan |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-06-05 |
Koenig Gerhard |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-06-05 |
Budd Haeberlein Samantha L. |
Director |
RSU-Zuteilung |
18,068 |
$3.38 |
$61.07K |
18,068 |
| 2024-05-03 |
Magovcevic-liebisch Ivana |
President and CEO |
Aktienrückgabe |
282,000 |
$16.13 |
$4.55M |
- |
| 2024-05-03 |
Thistle Mary |
Director |
Aktienrückgabe |
13,928 |
$10.00 |
$139.28K |
- |
| 2024-05-03 |
Blanchard Cheryl R |
Director |
Aktienrückgabe |
13,928 |
$10.00 |
$139.28K |
- |
| 2024-05-03 |
Booth Bruce |
Director |
Aktienrückgabe |
12,155 |
$3.10 |
$37.68K |
- |
| 2024-05-03 |
Bruhn Suzanne Louise |
Director |
Aktienrückgabe |
24,310 |
$6.93 |
$168.47K |
- |
| 2024-05-03 |
Ziolkowski Jennifer Lynn |
Chief Financial Officer |
Aktienrückgabe |
135,000 |
$11.87 |
$1.6M |
- |
| 2024-05-03 |
Vitorovic Stefan |
Director |
Aktienrückgabe |
13,928 |
$10.00 |
$139.28K |
- |
| 2024-05-03 |
Koenig Gerhard |
Director |
Aktienrückgabe |
13,928 |
$10.00 |
$139.28K |
- |
| 2024-05-03 |
Verni Christopher |
General Counsel |
Aktienrückgabe |
85,000 |
$11.87 |
$1.01M |
- |
| 2024-05-03 |
Gray David L. F. |
Chief Science Officer |
Aktienrückgabe |
267,000 |
$12.09 |
$3.23M |
- |
| 2024-05-03 |
Budd Haeberlein Samantha L. |
Director |
Aktienrückgabe |
13,928 |
$10.00 |
$139.28K |
- |
| 2024-03-18 |
Kaufmann Petra |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-03-18 |
Kaufmann Petra |
Chief Medical Officer |
RSU-Zuteilung |
330,000 |
$3.14 |
$1.04M |
330,000 |
| 2024-03-01 |
Magovcevic-liebisch Ivana |
President and CEO |
RSU-Zuteilung |
463,000 |
$3.39 |
$1.57M |
463,000 |
| 2024-03-01 |
Ziolkowski Jennifer Lynn |
Chief Financial Officer |
RSU-Zuteilung |
156,000 |
$3.39 |
$528.84K |
156,000 |
| 2024-03-01 |
Verni Christopher |
General Counsel |
RSU-Zuteilung |
116,000 |
$3.39 |
$393.24K |
116,000 |
| 2024-03-01 |
Gray David L. F. |
Chief Science Officer |
RSU-Zuteilung |
125,000 |
$3.39 |
$423.75K |
125,000 |
| 2024-03-01 |
Blanchard Cheryl R |
Director |
RSU-Zuteilung |
24,761 |
$3.39 |
$83.94K |
24,761 |
| 2024-03-01 |
Booth Bruce |
Director |
RSU-Zuteilung |
34,612 |
$3.39 |
$117.33K |
34,612 |
| 2024-03-01 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
24,073 |
$3.39 |
$81.61K |
24,073 |
| 2023-11-20 |
Magovcevic-liebisch Ivana |
President and CEO |
Informierter Kauf |
4,000 |
$3.75 |
$15K |
207,687 |
| 2023-08-07 |
Silber Christopher |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-08-07 |
Silber Christopher |
Chief Medical Officer |
RSU-Zuteilung |
330,000 |
$6.16 |
$2.03M |
330,000 |
| 2023-06-07 |
Thistle Mary |
Director |
RSU-Zuteilung |
13,928 |
$10.00 |
$139.28K |
13,928 |
| 2023-06-07 |
Blanchard Cheryl R |
Director |
RSU-Zuteilung |
13,928 |
$10.00 |
$139.28K |
13,928 |
| 2023-06-07 |
Booth Bruce |
Director |
RSU-Zuteilung |
13,928 |
$10.00 |
$139.28K |
13,928 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
